Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Statistics in Medicine|February 12, 2026
A Novel Method for Inserting Dose Levels Mid-Trial in Early-Phase Oncology Combination StudiesMatthew George, Ian Wadsworth, Pavel MozgunovStatistical Methods in Medical Research|January 24, 2024
A comparison of model-free phase I dose escalation designs for dual-agent combination therapiesHelen Barnett, Matthew George, Donia Skanji, et al.Statistics in Medicine|December 21, 2019
Improving safety of the continual reassessment method via a modified allocation rulePavel Mozgunov, Thomas JakiStatistics in Medicine|May 27, 2026
Computationally Efficient Approach to Operational Prior Specification in Phase I Clinical TrialsWeishi Chen, Pavel MozgunovJournal of the Royal Statistical Society. Series C, Applied Statistics|April 23, 2019
An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monotonicityPavel Mozgunov, Thomas JakiBiometrical Journal. Biometrische Zeitschrift|July 13, 2019
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpointsPavel Mozgunov, Thomas JakiStatistics in Medicine|January 24, 2025
On Inclusion of Covariates in Model Based Dose Finding Clinical Trial DesignsAdrien Ollier, Pavel MozgunovStatistical Methods in Medical Research|April 28, 2020
A surface-free design for phase I dual-agent combination trialsPavel Mozgunov, Mauro Gasparini, Thomas JakiComputational Statistics & Data Analysis|June 4, 2021
Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measuresKsenia Kasianova, Mark Kelbert, Pavel MozgunovBiostatistics (Oxford, England)|August 31, 2018
A benchmark for dose finding studies with continuous outcomesPavel Mozgunov, Thomas Jaki, Xavier PaolettiPageof 9